medigraphic.com

2018, Number 4

<< Back Next >>

Cir Cir 2018; 86 (4)

Metabolic changes in obese patients after laparoscopic gastric bypass: five-year experience in a tertiary referral hospital

Hernández-Marín JD, Marrufo-Patrón CA, López-Rosales F

Language: Spanish
References: 33
Page: 338-346
PDF size: 188.08 Kb.


ABSTRACT

Background: Obesity is defined as a disease characterized by an abnormal or excessive accumulation of adipose tissue that may be hazardous to the health. Bariatric surgery is an effective and safe treatment of morbid obesity. Materials and Methods: A review and analysis of 90 clinical records of postoperative patients with laparoscopic gastric bypass was performed. Results: 38 patients were included in the study; 17 (43.6%) of which were diagnosed with diabetes mellitus before the procedure and 21 patients (56.4%) without diabetes mellitus. In non-diabetic patients, it was found statistical differences in the value of body-mass index (BMI). In the group of diabetic patients, statistical differences were found in the value of BMI, glycated hemoglobin and uric acid. Conclusions: Laparoscopic gastric bypass (LRYGB) provides a satisfactory weight loss and BMI reduction, specifically, percent of excess BMI lost with the simultaneous improvement of comorbid disease.


REFERENCES

  1. Organización Mundial de la Salud (OMS), Obesidad y sobrepeso. Disponible en: http://www.who.int/es/news-room/fact-sheets/detail/obesity- and-overweight. Consultado Octubre 2017.

  2. Hussain SS, Bloom SR. The pharmacological treatment and management of obesity. Postgrad Med. 2011;123:34-44.

  3. Mechanick JI, Hurley DL, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: American Association of Clinical Endocrinologists and the American College of Endocrinology position statement. Endocr Pract. 2017;23:372-8.

  4. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino, 2016. Informe final de resultados. Disponible en: http://promocion.salud.gob mx/dgps/descargas1/doctos_2016/ensanut_ mc_2016-310oct pdf.

  5. Dávila-Torres J, González-Izquierdo JJ, Barrera-Cruz A. Panorama de la obesidad en México. Rev Med Inst Mex Seguro Soc. 2015; 53:240-9.

  6. Banegas JR, López-García E, Gutiérrez-Fisac JL, Guallar-Castillón P, Rodríguez-Artalejo F. A simple estimate of mortality attributable to excess weight in the European Union. Eur J Clin Nutr. 2003;57:201-8.

  7. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PF, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Surg Obes Relat Dis. 2016;12:1144-62.

  8. Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Fenj J, et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240:236-42.

  9. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467-84, discussion 484-5.

  10. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004;240:416-23.

  11. Adams TD, Gress RR, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-61.

  12. Pories WJ, Caro JF, Flickinger EG, Meelheim HD, Swanson MS. The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville Gastric Bypass. Ann Surg. 1987;206:316-23.

  13. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.

  14. Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945-52.

  15. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Poires WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-56.

  16. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomized controlled trial. Lancet. 2015;386:964-73.

  17. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017;376:641-51.

  18. Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, García L, et al. Seven-year trajectories and health outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) study. JAMA Surg. 2018;153:427-34.

  19. Choi HK, Mount DB, Reginato AM. Pathogenesis of gout. Ann Intern Med. 2005;143:499-516.

  20. McLean L. The pathogenesis of gout. En: Hochberg MC, editor. Reumathology. 3rd ed. Edinburgh: Mosby; 2003. p. 211-256

  21. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.

  22. Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565-8.

  23. Robert M, Ferrand-Gaillard C, Disse E, Espalieu P, Simon C, Laville M, et al. Predictive factors of type 2 diabetes remission 1 year after bariatric surgery: impact of surgical techniques. Obes Surg. 2013;23:770-5.

  24. Friedman JE, Dallal RM, Lord JL. Gouty attacks occur frequently in postoperative gastric bypass patients. Surg Obes Relat Dis. 2008;4:11-5.

  25. Dalberth N, Chen P, White M, Gamble GD, Barrat-Boyes C, Gow PJ, et al. Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study. Ann Rheum Dis. 2014;73:797-802.

  26. Hsu LK, Benotti PN, Dwyer J, Roberts SB, Saltzman E, Shikora S, et al. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med. 1998;60:338-46.

  27. Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18:648-51.

  28. Sarwer DB, Dilks RJ, West-Smith L. Dietary intake and eating behavior after bariatric surgery: threats to weight loss maintenance and strategies for success. Surg Obes Relat Dis. 2011;7 644-51.

  29. Sarwer DB, Moore RH, Spitzer JC, Wadden TA, Raper SE, Williams NN. A pilot study investigating the efficacy of postoperative dietary counseling to improve outcomes after bariatric surgery. Surg Obes Relat Dis. 2012;8:561-8.

  30. Vidal P, Ramón JM, Goday A, Parri A, Crous X, Trillo L, et al. Lack of adherence to follow-up visits after bariatric surgery: reasons and outcome. Obes Surg. 2014;24:179-83.

  31. Freire RH, Borges MC, Álvarez-Leite JI, Toulson Davisson Correia MI. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28:53-8.

  32. Gould JC, Beverstein G, Reinhardt S, Garren MJ. Impact of routine and long-term follow-up on weight loss after laparoscopic gastric bypass. Surg Obes Relat Dis. 2007;3 627-30.

  33. Westenhoefer J, Pudel V. Pleasure from food: importance for food choice and consequences of deliberate restriction. Appetite. 1993;20:246-9.




2020     |     www.medigraphic.com